Literature DB >> 16439436

Hippocampal atrophy in systemic lupus erythematosus.

S Appenzeller1, A D Carnevalle, L M Li, L T L Costallat, F Cendes.   

Abstract

OBJECTIVES: To determine the frequency and progression of hippocampal atrophy in systemic lupus erythematosus (SLE) and the clinical, laboratory and treatment features associated with its occurrence.
METHODS: 150 patients with SLE and 40 healthy volunteers were enrolled in our study. A complete clinical, laboratory and neurological evaluation was performed. Magnetic resonance imaging was carried out using a 2T scanner (Elscint Prestige) and coronal T1-weighted images were used for manual volumetric measurements. Atrophy was defined as values <2 standard deviations from the means of controls.
RESULTS: At entry into the study, the mean right and left hippocampal volumes of patients were significantly smaller than the hippocampal volumes of controls (p<0.001). After the follow-up magnetic resonance imaging, a significant progression of reduction in right and left hippocampal volumes in patients was observed (p<0.001). At entry, atrophy was identified in 43.9% and at follow-up in 66.7% of patients with SLE. Hippocampal atrophy was related to disease duration (p<0.001) total corticosteroid dose (p = 0.01) and history of central nervous system (CNS) manifestations (p = 0.01). Progression of atrophy was associated with cumulative corticosteroid dose (p = 0.01) and number of CNS events (p = 0.01). Patients with cognitive impairment had more severe hippocampal atrophy than those without.
CONCLUSION: Disease duration, total corticosteroid dose and greater number of CNS manifestations were associated with hippocampal atrophy in patients with SLE. A significant progression of hippocampal atrophy related to total corticosteroid dose and number of CNS events was observed. Further studies are necessary to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439436      PMCID: PMC1798450          DOI: 10.1136/ard.2005.049486

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  37 in total

1.  Effect of corticosteroids on short-term and long-term memory.

Authors:  R Brunner; D Schaefer; K Hess; P Parzer; F Resch; S Schwab
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

2.  The importance of accurate anatomic assessment for the volumetric analysis of the amygdala.

Authors:  L Bonilha; E Kobayashi; F Cendes; L M Li
Journal:  Braz J Med Biol Res       Date:  2005-03-08       Impact factor: 2.590

3.  The "steroid dementia syndrome": an unrecognized complication of glucocorticoid treatment.

Authors:  Owen M Wolkowitz; Sonia J Lupien; Erin Bigler; R Bronson Levin; Jonathan Canick
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

Review 4.  International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results.

Authors:  C Herrmann
Journal:  J Psychosom Res       Date:  1997-01       Impact factor: 3.006

Review 5.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

Authors: 
Journal:  Arthritis Rheum       Date:  1999-04

6.  Age- and sex-related effects on the neuroanatomy of healthy elderly.

Authors:  Hervé Lemaître; Fabrice Crivello; Blandine Grassiot; Annick Alpérovitch; Christophe Tzourio; Bernard Mazoyer
Journal:  Neuroimage       Date:  2005-04-13       Impact factor: 6.556

Review 7.  The acute effects of corticosteroids on cognition: integration of animal and human model studies.

Authors:  S J Lupien; B S McEwen
Journal:  Brain Res Brain Res Rev       Date:  1997-06

8.  Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe.

Authors:  T den Heijer; L J Launer; N D Prins; E J van Dijk; S E Vermeer; A Hofman; P J Koudstaal; M M B Breteler
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

Review 9.  Hippocampal remodeling and damage by corticosteroids: implications for mood disorders.

Authors:  E S Brown; A J Rush; B S McEwen
Journal:  Neuropsychopharmacology       Date:  1999-10       Impact factor: 7.853

10.  Glucocorticoid-induced impairment in declarative memory performance in adult humans.

Authors:  J W Newcomer; S Craft; T Hershey; K Askins; M E Bardgett
Journal:  J Neurosci       Date:  1994-04       Impact factor: 6.167

View more
  34 in total

Review 1.  Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.

Authors:  George K Bertsias; Dimitrios T Boumpas
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment.

Authors:  Meggan Mackay; An Vo; Chris C Tang; Michael Small; Erik W Anderson; Elisabeth J Ploran; Justin Storbeck; Brittany Bascetta; Simran Kang; Cynthia Aranow; Carl Sartori; Philip Watson; Bruce T Volpe; Betty Diamond; David Eidelberg
Journal:  JCI Insight       Date:  2019-01-10

Review 3.  Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches.

Authors:  Aida Zarfeshani; Kaitlin R Carroll; Bruce T Volpe; Betty Diamond
Journal:  Curr Rheumatol Rep       Date:  2021-03-29       Impact factor: 4.592

4.  Unpredictable Chronic Mild Stress Paradigm Established Effects of Pro- and Anti-inflammatory Cytokine on Neurodegeneration-Linked Depressive States in Hamsters with Brain Endothelial Damages.

Authors:  Ennio Avolio; Gilda Fazzari; Maria Mele; Raffaella Alò; Merylin Zizza; Wei Jiao; Anna Di Vito; Tullio Barni; Maurizio Mandalà; Marcello Canonaco
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

5.  Neurological Manifestations in Systemic Lupus Erythematosus: A Single Centre Study from North East India.

Authors:  Sanjeeb Kakati; Bhupen Barman; Sobur U Ahmed; Masaraf Hussain
Journal:  J Clin Diagn Res       Date:  2017-01-01

Review 6.  Therapeutic potential of SIGIRR in systemic lupus erythematosus.

Authors:  Chao Wang; Chen-Chen Feng; Hai-Feng Pan; De-Guang Wang; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-04-02       Impact factor: 2.631

7.  Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus.

Authors:  Rex E Jung; Judith M Segall; Rachael G Grazioplene; Clifford Qualls; Wilmer L Sibbitt; Carlos A Roldan
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

Review 8.  Neurologic manifestations of systemic lupus erythematosus in children and adults.

Authors:  Eyal Muscal; Robin L Brey
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

Review 9.  Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction.

Authors:  Philip Watson; Justin Storbeck; Paul Mattis; Meggan Mackay
Journal:  Neuropsychol Rev       Date:  2012-08-11       Impact factor: 7.444

10.  Juvenile systemic lupus erythematosus with primary neuropsychiatric presentation.

Authors:  Nélia Ferraria; Susana Rocha; Vera Silva Fernandes; Teresa Correia; Elisabete Gonçalves
Journal:  BMJ Case Rep       Date:  2013-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.